Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model
Crossref DOI link: https://doi.org/10.1186/cc14431
Published Online: 2015-03-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Honickel, M
Braunschweig, T
Ryn, J Van
Rossaint, R
Grottke, O
Text and Data Mining valid from 2015-03-16
Version of Record valid from 2015-03-16
Article History
First Online: 16 March 2015
Free to read: This content has been made available to all.